Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Cyclopentanohydrophenanthrene ring system doai
Patent
1991-08-26
1993-06-29
Shah, Mukund J.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Cyclopentanohydrophenanthrene ring system doai
514177, 540114, 552553, C07J 500, C07J 1700, A61K 31575, A61K 3158
Patent
active
052234924
ABSTRACT:
This invention relates to the field of chemistry and more precisely to the field of medicinal Chemistry.
It has specifically as subject matter the compounds of general formula I ##STR1## wherein R is a hydrogen, a lower alkyl radical a methoxymethyl, a tetrahydropyranyl or the acyl residue of an organic carboxylic.
REFERENCES:
patent: 3018295 (1962-01-01), Berg et al.
patent: 4544555 (1985-10-01), Gastaud
patent: 4720357 (1988-01-01), Tchernatinsky
Krubineir, et al., J. Org. Chem. vol. 33 (5) 1968 pp. 1715-1718.
March Advanced Organic Chemistry 2nd Ed. [New York, McGraw-Hill Book, 1979] pp. 864-872.
Cooley, et al., Chemical Abstracts, vol. 63, 1965 Abstract 116502-h.
Nasraoui Nejib M.
Piasco Alain
Shah Mukund J.
Ward E. C.
LandOfFree
Derivatives of 19-nor progesterone; process for producing them a does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Derivatives of 19-nor progesterone; process for producing them a, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Derivatives of 19-nor progesterone; process for producing them a will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1755430